Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Topical Putrescine (Fibrostat) in 10%Urea (TFU) for Prevention of Hypertrophic Scars in Mammoplasty Patients

NCT03376620 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT03376620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03376620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Topical Putrescine (Fibrostat) in 10%Urea (TFU) for Prevention of Hypertrophic Scars in Mammoplasty Patients
Lead sponsor
University of Manitoba
Phase
Phase 3
Overall status
Completed
Start date
September 2, 2011
Completion date
July 15, 2016
Enrollment
56 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scar